Vanderbilt-Ingram Cancer Center

Black women have the highest mortality rate of all women with breast cancer in the U.S., with a significant number presenting at an earlier age of diagnosis and with more advanced-stage disease.

Early-onset colorectal cancer did not appear genomically distinct from average-onset disease, according to results of a retrospective, single-institution analysis published in Journal of the National Cancer Institute.

Pembrolizumab plus axitinib continued to exhibit superior efficacy to sunitinib as first-line therapy for advanced clear cell renal cell carcinoma, according to long-term follow-up of the randomized phase 3 KEYNOTE-426 trial.

National Comprehensive Cancer Network guidelines recommend all patients with advanced nonsquamous non-small cell lung cancer undergo biomarker testing.

Sotorasib conferred durable clinical benefit among previously treated patients with KRAS p.G12C-mutated non-small cell lung cancer, according to results of the phase 2 CodeBreaK 100 trial presented during the virtual ASCO Annual Meeting.

Black patients with early-onset, microsatellite-stable colorectal cancer had substantially higher tumor mutational burden than their white counterparts, according to study results.

The FDA approved tivozanib for treatment of adults with relapsed or refractory advanced renal cell carcinoma.

Global Cancer Institute has appointed two oncologists to serve as co-chief medical officers.

Ensartinib significantly increased PFS compared with crizotinib for patients with anaplastic lymphoma kinase-positive non-small cell lung cancer, according to an interim analysis of the phase 3, open-label eXalt3 study.

Hydroxychloroquine in combination with other treatments for COVID-19 appeared associated with increased mortality among patients with cancer, study results showed.